IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Sanofi-Aventis to Establish Biotech Facility in France

7:30 AM MDT | May 11, 2009 | DEEPTI RAMESH

Sanofi-Aventis (Paris) says it has started up the “Biolaunch project” at its Vitry-sur-Seine (France) pharmaceutical production site. The €200-million ($266 million) project will provide the company with its first cell-culture biotechnoloy platform by 2012 for monoclonal antibody production, Sanofi-Aventis says. The project includes R&D and production. Sanofi-Aventis says it plans to make the facility available to other companies, based on their development or production needs. The project is part of Sanofi-Aventis’s long-term strategy...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa